Rite Aid employs 45,000 people, of which more than 6,100 are pharmacists, the company said in the court documents
If the next few years confirm these early results, oral GLP-1 therapies could become a cornerstone of modern obesity care helping more people get treatment that fits their lives
These typically occur in 20-40% of patients and include: Nausea (most common, especially during dose increases) Vomiting Diarrhea Stomach pain Decreased appetite Constipation These side effects usually improve over time as your body adjusts to the medication
Semaglutide and tirzepatide achieve approximately 15-20% body weight reduction in clinical trials
Starting a GLP-1 medication such as Wegovy, Ozempic, Zepbound, or Mounjaro can be an exciting step toward better health and sustainable weight loss
for example, if your ferritin (iron stores) is low, your thyroid medication may not work effectively